These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11267531)

  • 21. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.
    Maisonneuve P; Agodoa L; Gellert R; Stewart JH; Buccianti G; Lowenfels AB; Wolfe RA; Jones E; Disney AP; Briggs D; McCredie M; Boyle P
    Lancet; 1999 Jul; 354(9173):93-9. PubMed ID: 10408483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Canadian Organ Replacement Register on renal replacement therapy.
    Schaubel DE; Parsons DA; Hall NI; Fenton SS
    Nephrol News Issues; 1997 Sep; 11(9):23-4, 35. PubMed ID: 9348868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttransplant malignancies.
    Penn I
    Transplant Proc; 1999; 31(1-2):1260-2. PubMed ID: 10083562
    [No Abstract]   [Full Text] [Related]  

  • 24. End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.
    Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW
    Am J Nephrol; 2015; 42(3):177-84. PubMed ID: 26418732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dialysis modality, vascular access and mortality in end-stage kidney disease: A bi-national registry-based cohort study.
    Kasza J; Wolfe R; McDonald SP; Marshall MR; Polkinghorne KR
    Nephrology (Carlton); 2016 Oct; 21(10):878-86. PubMed ID: 26630249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal transplantation for Indigenous Australians: identifying the barriers to equitable access.
    Cass A; Cunningham J; Snelling P; Wang Z; Hoy W
    Ethn Health; 2003 May; 8(2):111-9. PubMed ID: 14671765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer statistics: everything you wanted to know about the cancer registry data but were too afraid to ask.
    Giles GG; Thursfield V
    ANZ J Surg; 2004 Nov; 74(11):931-4. PubMed ID: 15550077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospitalizations for bacterial septicemia in patients with end stage renal disease due to diabetes on the renal transplant waiting list.
    Abbott KC; Napier MG; Agodoa LY
    J Nephrol; 2002; 15(3):248-54. PubMed ID: 12113595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asian transplant registry (1999).
    Ota K
    Transplant Proc; 2001; 33(1-2):1989-92. PubMed ID: 11267598
    [No Abstract]   [Full Text] [Related]  

  • 31. Foreword: Veneto Dialysis and Transplantation Registry, 2008-2010 report.
    Antonucci F
    J Nephrol; 2013; 26 Suppl 20():S1. PubMed ID: 24293192
    [No Abstract]   [Full Text] [Related]  

  • 32. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.
    Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
    Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Kidney transplanted persons with malignant tumors is a growing patient group].
    Hellström V; Wilczek H; Roussos J; Lorant T; Enblad G; Nyberg F; Tufveson G
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1766-9. PubMed ID: 23097887
    [No Abstract]   [Full Text] [Related]  

  • 34. Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10.
    Elwood JM; Aye PS; Tin Tin S
    PLoS One; 2016; 11(3):e0150734. PubMed ID: 26938056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventable kidney failure: the cost of diabetes neglect?
    Endre ZH; Beaven D; Buttimore A
    N Z Med J; 2006 Dec; 119(1246):U2338. PubMed ID: 17151712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cancer survival in New Zealand and Australia, 2006-2010.
    Aye PS; Elwood JM; Stevanovic V
    N Z Med J; 2014 Dec; 127(1407):14-26. PubMed ID: 25530328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012.
    Clayton PA; Saunders JR; McDonald SP; Allen RD; Pilmore H; Saunder A; Boudville N; Chadban SJ
    Transplantation; 2016 Jun; 100(6):1278-83. PubMed ID: 27123877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine.
    Lim WH; Russ GR; Wong G; Pilmore H; Kanellis J; Chadban SJ
    Kidney Int; 2017 Apr; 91(4):954-963. PubMed ID: 28109543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Access to the kidney transplant waiting list: a time for reflection.
    Pussell BA; Bendorf A; Kerridge IH
    Intern Med J; 2012 Apr; 42(4):360-3. PubMed ID: 22498116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.
    See EJ; Hawley CM; Cho Y; Toussaint ND; Agar JW; Pascoe EM; Lim WH; Francis RS; Collins MG; Johnson DW
    Nephrology (Carlton); 2019 Jan; 24(1):111-120. PubMed ID: 29316017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.